Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients
Hamed Valizadeh, Samaneh Abdolmohammadi‐Vahid, Svetlana Danshina, et al.
International Immunopharmacology (2020) Vol. 89, pp. 107088-107088
Open Access | Times Cited: 237

Showing 1-25 of 237 citing articles:

Drug treatments for covid-19: living systematic review and network meta-analysis
Reed Siemieniuk, Jessica Bartoszko, Dena Zeraatkar, et al.
BMJ (2020), pp. m2980-m2980
Open Access | Times Cited: 793
Anti-Inflammatory Effects of Curcumin in the Inflammatory Diseases: Status, Limitations and Countermeasures
Ying Peng, Mingyue Ao, Dong BaoHua, et al.
Drug Design Development and Therapy (2021) Vol. Volume 15, pp. 4503-4525
Open Access | Times Cited: 405
COVID‐19: Virology, biology and novel laboratory diagnosis
Malihe Mohamadian, Hossein Chiti, Alireza Shoghli, et al.
The Journal of Gene Medicine (2020) Vol. 23, Iss. 2
Open Access | Times Cited: 345
A Comprehensive Review on the Therapeutic Potential of Curcuma longa Linn. in Relation to its Major Active Constituent Curcumin
Shivkanya Fuloria, Jyoti Mehta, Aditi Chandel, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 207
Curcumin: Biological Activities and Modern Pharmaceutical Forms
Maja Urošević, Ljubiša Nikolić, Ivana Gajić, et al.
Antibiotics (2022) Vol. 11, Iss. 2, pp. 135-135
Open Access | Times Cited: 180
Traditional Chinese medicine in COVID-19
Ming Lyu, Guanwei Fan, Guangxu Xiao, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 11, pp. 3337-3363
Open Access | Times Cited: 169
Curcumin Nanoparticles as Promising Therapeutic Agents for Drug Targets
Hitesh Chopra, Protity Shuvra Dey, Debashrita Das, et al.
Molecules (2021) Vol. 26, Iss. 16, pp. 4998-4998
Open Access | Times Cited: 160
The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions
Valentina Carlini, Douglas M. Noonan, Eslam Abdalalem, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 133
Curcumin as a Potential Treatment for COVID-19
Bruna Rattis, Simone G. Ramos, Mara Rúbia Nunes Celes
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 124
Overview of the Antioxidant and Anti-Inflammatory Activities of Selected Plant Compounds and Their Metal Ions Complexes
Paulina Mucha, Anna Skoczyńska, Magdalena Małecka, et al.
Molecules (2021) Vol. 26, Iss. 16, pp. 4886-4886
Open Access | Times Cited: 124
Effectiveness of Curcumin on Outcomes of Hospitalized COVID-19 Patients: A Systematic Review of Clinical Trials
Amir Vahedian‐Azimi, Mitra Abbasifard, Farshid Rahimi‐Bashar, et al.
Nutrients (2022) Vol. 14, Iss. 2, pp. 256-256
Open Access | Times Cited: 114
Curcumin Formulations for Better Bioavailability: What We Learned from Clinical Trials Thus Far?
Mangala Hegde, Sosmitha Girisa, Bandari BharathwajChetty, et al.
ACS Omega (2023) Vol. 8, Iss. 12, pp. 10713-10746
Open Access | Times Cited: 96
Antioxidant and anti-inflammatory effects of curcumin/turmeric supplementation in adults: A GRADE-assessed systematic review and dose–response meta-analysis of randomized controlled trials
Mohammad Jafar Dehzad, Hamid Ghalandari, Mehran Nouri, et al.
Cytokine (2023) Vol. 164, pp. 156144-156144
Closed Access | Times Cited: 87
Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials
Ajaikumar B. Kunnumakkara, Mangala Hegde, Parama Dey, et al.
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 4, pp. 447-518
Open Access | Times Cited: 70
An overview on the treatments and prevention against COVID-19
Yunes Panahi, Armita Mahdavi Gorabi, Sona Talaei, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 46
Curcumin-Based Nanomedicines in the Treatment of Inflammatory and Immunomodulated Diseases: An Evidence-Based Comprehensive Review
Lucas Fornari Laurindo, Gabriel Magno de Carvalho, Bárbara de Oliveira Zanuso, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 229-229
Open Access | Times Cited: 45
Curcumin Supplementation and Human Disease: A Scoping Review of Clinical Trials
Timothy Panknin, Carol Howe, Meg Hauer, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4476-4476
Open Access | Times Cited: 39
Curcumin-based Nanoformulations As an Emerging Therapeutic Strategy for Inflammatory Lung Diseases
Asif Ahmad Bhat, Riya Thapa, Ahsas Goyal, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 7, pp. 583-586
Closed Access | Times Cited: 39
Effect of nano‐curcumin on various diseases: A comprehensive review of clinical trials
Shirin Hassanizadeh, Mehrnaz Shojaei, Mohammad Bagherniya, et al.
BioFactors (2023) Vol. 49, Iss. 3, pp. 512-533
Closed Access | Times Cited: 37
Longevity and anti-aging effects of curcumin supplementation
Mehran Izadi, Nariman Sadri, Amirhossein Abdi, et al.
GeroScience (2024) Vol. 46, Iss. 3, pp. 2933-2950
Open Access | Times Cited: 11
RETRACTED: Immunomodulatory effects of nanocurcumin on Th17 cell responses in mild and severe COVID‐19 patients
Safa Tahmasebi, Mohamed A. El‐Esawi, Zaid Hameed Mahmoud, et al.
Journal of Cellular Physiology (2020) Vol. 236, Iss. 7, pp. 5325-5338
Closed Access | Times Cited: 108
COVID-19, cytokines, inflammation, and spices: How are they related?
Ajaikumar B. Kunnumakkara, Varsha Rana, Parama Dey, et al.
Life Sciences (2021) Vol. 284, pp. 119201-119201
Open Access | Times Cited: 95
Antimicrobial Activity of Curcumin in Nanoformulations: A Comprehensive Review
Jeffersson Krishan Trigo-Gutierrez, Yuliana Vega-Chacón, Amanda Brandão Soares, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 7130-7130
Open Access | Times Cited: 93
Chronic Inflammatory Diseases, Anti-Inflammatory Agents and Their Delivery Nanosystems
Daniela Plachá, Josef Jampílek
Pharmaceutics (2021) Vol. 13, Iss. 1, pp. 64-64
Open Access | Times Cited: 85
Curcumin Inhibits In Vitro SARS-CoV-2 Infection In Vero E6 Cells through Multiple Antiviral Mechanisms
Damariz Marín-Palma, Jorge H. Tabares-Guevara, María I. Zapata-Cardona, et al.
Molecules (2021) Vol. 26, Iss. 22, pp. 6900-6900
Open Access | Times Cited: 84
Page 1 - Next Page

Scroll to top